Immunity to varicella zoster virus among young adults: A decline prior to widespread uptake of varicella vaccines

Infection

Volumn 36, Issue 2, 2008, Pages 130-134

  Grotto, I ^a   Balicer, R D ^a,b   Smetana, Z ^c   Davidovitch, N ^a   Bar Zeev, Y ^b   Mendelson, E ^c   Zarka, S ^b,d   Huerta, M ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MEDICAL CORPS   (Israel)

^c MINISTRY OF HEALTH   (Israel)

^d UNIVERSITY OF HAIFA   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; HERPES ZOSTER IMMUNOGLOBULIN;

ADULT; ANTIBODY DETECTION; ARTICLE; EDUCATION; HEALTH CARE POLICY; HERPES ZOSTER; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; SEROPREVALENCE; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; VIRUS IMMUNITY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HERPESVIRUS 3, HUMAN; HUMANS; ISRAEL; MALE; SEROEPIDEMIOLOGIC STUDIES;

EID: 42249112669     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-7192-7     Document Type: Article

References (26)

1. Gershon AA, LaRussa P: Varicella zoster virus infections. In: Krugman S (Ed. Infectious diseases of childhood. Mosby Year Book, St. Louis 1992, pp 587-614.
2. Choo PW, Donahue JG, Manson JE: The epidemiology of varicella and its complications. J Infect Dis 1995; 172: 706-712.
3. Pastuszak AL, Levy M, Schick B, Zuber C, Feldkamp M, Gladstone J, Fanny Bar-Levy F, Jackson E, Donnenfeld A, Meschino Koren A Gl: Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994; 330: 901-905.
4. Feldman S, Moffitt JE: Varicella vaccine. Pediatr Ann 1990; 19: 721-726.
5. Avrahami-Heller Y, Cohen D, Orr N, Slepon R, Ashkenazi I, Danon YL: Immunity to varicella zoster virus in young Israeli adults. Isr Med Assoc J 2000; 2: 196-199.
6. Huerta M, Davidovitch N, Aboudy Y, Ankol OE, Balicer RD, Zarka S, Grotto I: Declining population immunity to mumps among Israeli military recruits. Vaccine 2006; 24: 6300-6303.
7. Smetana Z, Leventon-Kriss S, Broide A, Jedwab M, Smetana SS: Varicella Zoster virus Immune status in CAPD and chronic hemodialysis patients. Am J Nephrol 1991; 11: 229-236.
8. de Ory F, Echevarría JM, Kafatos G, Anastassopoulou C, Andrews N, Backhouse J, Berbers G, Bruckova B, Cohen DI, de Melker H, Davidkin I, Gabutti G, Hesketh LM, Johansen K, Jokinen S, Jones L, Linde A, Miller E, Mossong J, Nardone A, Rota MC, Sauerbrei A, Schneider F, Smetana Z, Tischer A, Tsakris A, Vranckx R: European seroepidemiology network 2: Standardization of assays for seroepidemiology of varicella zoster virus. J Clin Virol 2006; 36: 111-118.
9. Abramson J, Gahlinger PM: Computer programs for epidemiologists: PEPI Version 3. Stone Mountain, Georgia, USA Inc, 1999.
10. Cohen DI, Davidovici BB, Smetana Z, Balicer RD, Klement E, Mendelson E, Green MS: Seroepidemiology of Varicella zoster in Israel Prior to Large-scale Use of Varicella Vaccines. Infection 2006; 34: 208-213.
11. Chodik G, Ashkenazi S, Livni G, Lerman Y: Increased susceptibility to Varicella-Zoster virus among Israeli physicians born in the Middle-East region. J Occup Health 2006; 48: 246-252.
12. Musharrafieh UM, Nuwayhid IA, Hamadeh GN, Steitieh SW, Bizri AR: Immunity to chickenpox among school adolescents in Lebanon and options for vaccination. Epidemiol Infect 2002; 129: 607-615.
13. Kurugol Z, Koturoglu G, Aksit S, Ozacar T: Varicella seroprevalence in Turkish population in Cyprus. Acta Paediatr 2007; 96: 861-863.
14. Khoshnood B, Debruyne M, Emery C, Fagnani F, Durand I, Floret D: Seroprevalence of varicella in the French population. Pediatr Infect Dis J 2006; 25: 41-44.
15. Alp H, Altinkaynak S, Ertekin V, Giiraksin A: Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey. Health Policy 2005; 72: 119-124.
16. Zimmerman L, Fajardo M, Seward J, Ludwig S, Johnson J, Wharton M: Varicella susceptibility and validity of history among U.S. Coast Guard recruits: an outbreak-based study. Mil Med 2003; 168: 404-407.
17. Ryan MA, Smith TC, Honner WK, Gray GC: Varicella susceptibility and vaccine use among young adults enlisting in the United States Navy. J Med Virol 2003; 70: S15-S19.
18. Alvarez y Munoz MT, Torres J, Damasio-Santana L, Gomez A, Fernandez-Quintanilla G, Tapia-Conyer R, Munoz O: Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico. Arch Med Res 1999; 30: 60-63.
19. Gray G, Palinkas L, Kelley P: Increasing incidence of varicella hospitalizations in the United States army and navy personnel: are today's teenagers more suceptible? Pediatrics 1990; 86: 867-873.
20. Weller TH: Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus. N Engl J Med 1983; 309: 1434-1440.
21. Struewing JP, Hyams KC, Tueller JE, Gray GC: The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits. Am J Public Health 1993; 83: 1717-1720.
22. Green MS, Shohat T, Lerman Y, Cohen D, Slepon R, Duvdevani P, Varsano N, Dagan R, Mendelson E: Sex differences in the humoral antibody response to live measles vaccine in young adults. Int J Epidemiol 1994; 23: 1078-1081.
23. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, Maupin TJ, Goldman GS, Tabony LJ, Brodovicz KG, Jumaan AO, Wharton M: Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002; 287: 606-611.
24. Balicer RD, Levin H, Zarka S: Annual IDF epidemiologic report. IDF Medical Corps Publications, Tel Hashomer, 2005, pp. 53-55.
25. Center for Disease Control and Prevention Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48: 1-5.
26. Diez-Domingo J, Gil A, San-Martín M, González A, Esteban J, Baldó JM, Planelles MV, Ubeda MI, Graullera M, Peris A, Martínez M, Antón V, Gallego D, Alvarez T, Villarroya JV, Jubert A, Casaní C, Peidró C, García M, Ballester A: Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent's reported history and the medical file for identification of potential candidates for vaccination. Hum Vaccin 2005; 1: 204-206.